Literature DB >> 3487159

Pyometra.

R W Nelson, E C Feldman.   

Abstract

Pyometra is a relatively uncommon diestral uterine disorder seen primarily in older bitches and queens. The incidence of pyometra appears to be increasing, especially in younger animals, as a result of increasing use of estrogen and progesterone for mismating and for certain medical disorders. The clinical signs of pyometra and abnormalities on physical examination are dependent on the patency of the cervix and how quickly the client recognizes the problem. Ovariohysterectomy is still the treatment of choice; however, prostaglandin F2 alpha as a medical alternative in the management of pyometra is gaining more and more acceptance. The goal of prostaglandin F2 alpha therapy is to salvage the reproductive tract in the young breeding bitch or queen in the hopes of obtaining future litters. The results have been very promising, especially for bitches or queens with open-cervix pyometra. Prostaglandin F2 alpha appears to offer the owner a reasonable alternative in the management of pyometra.

Entities:  

Mesh:

Year:  1986        PMID: 3487159     DOI: 10.1016/s0195-5616(86)50061-9

Source DB:  PubMed          Journal:  Vet Clin North Am Small Anim Pract        ISSN: 0195-5616            Impact factor:   2.093


  3 in total

1.  Pyometra in bitches induces elevated plasma endotoxin and prostaglandin F2alpha metabolite levels.

Authors:  R Hagman; H Kindahl; A S Lagerstedt
Journal:  Acta Vet Scand       Date:  2006       Impact factor: 1.695

2.  Changes in the Salivary Proteome Associated With Canine Pyometra.

Authors:  Lorena Franco-Martínez; Anita Horvatić; Andrea Gelemanović; Marko Samardžija; Vladimir Mrljak; María Dolores Contreras-Aguilar; Silvia Martínez-Subiela; Roman Dąbrowski; Asta Tvarijonaviciute
Journal:  Front Vet Sci       Date:  2020-06-11

3.  Kynurenic acid in plasma and endometrium in bitches with pyometra.

Authors:  Roman Dąbrowski; Tomasz Kocki; Marek Szczubiał; Wojciech Dąbrowski; Jolanta Parada-Turska
Journal:  Inflammation       Date:  2013-02       Impact factor: 4.092

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.